Abstract 3,4-Dihydroxyphenylalanine decarboxylase (DDC; also known as L-amino acid decarboxylase) is involved in the synthesis of dopamine, norepinephrine, and serotonin, and also acts as an androgen receptor co-regulator protein. In contrast to other amino acid decarboxylases that are modulated by sex hormones, little is known about the influence of these hormones on DDC regulation. In the present work, we studied the influence of gender in the expression of DDC in different mouse tissues. Among the different organs studied, including brain, liver, kidney, intestine, heart, adrenal gland, and skeletal muscle, only kidney and small intestine showed a sex-dependent dimorphism in DDC expression. In the kidney, levels of DDC activity, DDC mRNA, and protein were remarkably higher in females than in males. On the contrary, in the small intestine, male mice displayed higher levels of DDC activity than females but they did not correlate precisely with mRNA levels. This dimorphism was dependent on androgens, since male castration and treatment of female mice with testosterone propionate, oppositely affected DDC levels in kidney and small intestine. However, estrogen ablation or treatment with estradiol did not significantly affect DDC activity in these tissues. Immunocytochemical analysis revealed that DDC was mainly located in the proximal straight tubular cells of the kidney and in the cytoplasm of enterocytes. These data and the fact that renal DDC inversely correlated with renal sodium reabsorption suggest that renal and intestinal gender dimorphism in DDC could be related to sexrelated differences in sodium balance observed between males and females.
Introduction
The enzymatic synthesis of the biogenic amines dopamine, histamine, putrescine, and agmatine involves the decarboxylation of the corresponding amino acid by its cognate amino acid decarboxylase (Hayashi et al. 1990a ,b, Sandmeier et al. 1994 , Viguera et al. 1994 , Zhu & Juorio 1995 , Pegg 2006 , Kidron et al. 2007 ). More specifically, the key step in the formation of the aromatic amines dopamine, epinephrine, and norepinephrine is catalyzed by a single enzyme named 3,4-dihydroxyphenylalanine (DOPA) decarboxylase (DDC, EC 4.1.1.28) since it can convert L-DOPA into dopamine (Christenson et al. 1972 , Zhu & Juorio 1995 , Berry et al. 1996 . Because this enzyme may also decarboxylate other aromatic amino acids, such as 5-hydroxytryptophan, tryptophan, phenylalanine, and tyrosine, producing their corresponding amines 5-hydroxytryptamine, tryptamine, phenylethylamine, and tyramine, it is also named aromatic L-amino acid decarboxylase (AADC).
The enzyme has been characterized from different mammalian tissues, especially brain, liver, kidney, pancreas, adrenal glands, and placenta (Fellman 1959 , Lovenberg 1971 , Lindström 1986 , Hayashi et al. 1990a ,b, Siaterli et al. 2003 . The renal enzyme from pig and guinea pig has been extensively purified and its kinetic and structural properties have been thoroughly studied (O'Learly & Baughn 1977 , Dominici et al. 1985 , 1993 . cDNAs from rat and human DDC have been cloned and sequenced (Ichinose et al. 1989 , Tanaka et al. 1989 ) and the structure and sequence of other mammalian DDC genes, including murine DDC, are already available from GeneBank databases. Most studies on the physiological function of the DDC have been carried out on the enzyme from neuronal tissues where the decarboxylase is clearly related to the formation of biogenic active amines that act as neurotransmitters or neuromodulators (Molinoff & Axelrod 1971 , Carlsson 1987 . In extra-neural tissues, the enzyme activity has been associated with both amine synthesis and catabolism of aromatic amino acids (Rahman et al. 1981) , and most of the in vivo studies on the peripheral DDC have focused mainly on its inhibition in order to improve L-DOPA therapy in Parkinson's disease (Da Prada 1985) . However, several studies have pointed out that the enzyme may participate in the regulation of different physiological processes in peripheral tissues. Thus, in the rat kidney, it has been suggested that tubular DDC and its product dopamine may affect sodium absorption by renal epithelial cells (Bertorello et al. 1988 , Vieira-Coelho et al. 2000 . In the mouse, the high DDC activity found in the pancreatic islets has been related with a stimulatory effect on insulin secretion (Lindström 1986 ). Dopamine and serotonin, DDC products, play crucial roles in the behavior and development of insects (Hodgetts & O'Keefe 2006) , having been demonstrated that DDC could also participate in the regulation of Drosophila lifespan (De Luca et al. 2003) . Interestingly, it has been shown that DDC binds and enhances the transcriptional activity of androgen receptors (AR; Wafa et al. 2003) , which indicates that DDC may exert actions independently of its catalytic activity. In addition, other so-far-undetermined functions cannot be excluded.
The properties and regulatory mechanisms of the mammalian amino acid decarboxylases that generate biogenic amines have been extensively studied, especially for those decarboxylating histidine and ornithine (Moya-Garcia et al. 2004 , Pegg 2006 . Both enzymes exhibit a sexual dimorphic pattern in different murine tissues. In this regard, it is known that there is a marked sexual extra-genital dimorphism in the kidney, liver, and skeletal muscle in several mouse strains, affecting many different proteins (Bardin & Catterall 1981) . In particular, renal ornithine decarboxylase (ODC) activity is remarkably higher in males than in females, and the treatment of females with testosterone elicits a dramatic increase of ODC activity in renal tissue (Henningsson et al. 1978 , Melatinou et al. 1987 , Sánchez-Capelo et al. 1994 , mediated by transcriptional, translational, and post-translational mechanisms (Seely et al. 1982 , Kontula et al. 1984 , Berger & Watson 1989 . On the other hand, renal histidine decarboxylase is up-regulated by estrogens and repressed by androgens (Grahn et al. 1973 , Middleton et al. 1987 , Middleton & Bulfield 1988 . In contrast, little is known about the influence of sex hormones on the regulation of DDC in murine tissues. The possible existence of sexual dimorphism in catecholamine metabolism could be of potential interest to explain gender-dependent differences in response to stress. In this respect, it is widely accepted that a better knowledge of the biochemical and physiological differences between sexes may be of great relevance for the prevention, diagnosis, and treatment of many human diseases (Marts & Keitt 2004) .
In the present work, we have studied the influence of sex on DDC activity in different mouse tissues. We demonstrate, for the first time, the existence of a marked and opposite sexual dimorphism of DDC in the intestine and kidney of mice, affecting DDC activity and protein. Moreover, we postulate that this DDC dimorphism may have physiological relevance in sodium homeostasis, mainly through the modulation of sodium absorption by the kidney.
Materials and Methods

Animals and treatments
Immature and adult Swiss CD1 mice were bred in the animal house facilities of the University of Murcia. Before weaning, pups were maintained with dams in individual cages. After weaning, animals were fed with standard chow (UAR A03, Panlab, Barcelona, Spain) and water ad libitum. The sodium and potassium content of this diet were 2500 and 5600 mg/kg respectively. Animals were maintained at 22 8C ambient temperature and 50% relative humidity under a controlled 12 h light:12 h darkness cycle (lights on at 0800 h). To collect urine, mice were kept in metabolic boxes for 4 days and urine collected daily. Several groups of control and treated mice were used in different experiments. Two groups of 3-monthold male mice (weighing 38-41 g) and female mice (weighing 27-30 g) were gonadectomized under ether anesthesia and used 15 days after surgery. A subgroup of castrated males was injected with 17b-estradiol benzoate (50 mg/kg body weight, sc, daily) and mice were killed after 2 weeks of treatment. Another group of intact male mice was treated with the antiandrogen flutamide; mice were injected sc with flutamide (25 mg/kg body weight, 4 injections, 12 h apart) and killed 48 h after the first injection. Two groups of intact adult females were injected with testosterone propionate under two different schedules: in the first subgroup, a single sc injection of testosterone (20 mg/kg body weight) was given at 0900 h and the mice were killed 24 or 48 h after injection; and in the second subgroup, animals were injected with testosterone propionate (20 mg/kg body weight) every other day and killed after 2 weeks of treatment. In all cases, animals were killed by cervical dislocation and the organs were quickly removed, weighed, and processed. In the case of the intestine, tissues were cut into the desired segments, washed thrice with cold 0 . 9% saline solution before homogenization. A 2 cm segment of the small intestine adjacent to the pyloric sphincter was taken as duodenum, a 2 cm segment of the middle portion of the small intestine was taken as jejunum, and a 2 cm segment of the small intestine adjacent to the cecum was taken as ileum. Procedures involving animals and their care were conducted in conformity with the institutional guidelines of the University of Murcia that are in compliance with national laws and policies (RD 1201 (RD /2005 ).
Measurement of DDC activity
For enzyme determination, tissues were homogenized with the aid of a Polytron homogenizer in a buffer containing 25 mM Tris (pH 7 . 2), 2 mM dithiothreitol, 0 . 1 mM pyridoxal phosphate, 0 . 1 mM EDTA, and 0 . 25 M sucrose (1:5, w:v) .
The homogenate was centrifuged at 12 000 g for 20 min, and DDC activity was determined in the supernatant by measuring 14 CO 2 release from 1-14 C DOPA, using a protocol similar to the one used for measuring ODC activity (Bastida et al. 2005) . In brief, the incubation mixture contained 20 mM Tris pH 7 . 2, 0 . 1 mM pyridoxal phosphate, 0 . 1 mM EDTA, 2 mM dithiothreitol, 1 . 30 mM L-DOPA, and 0 . 03 mM DOPA, DL- 3,4-alanine 1-14 C ( 14 C-DOPA, American Radiolabeled Chemicals Inc., St Louis, MO, USA, specific activity 54 mCi/mmol) in a total volume of 62 . 5 ml. The samples were incubated at 37 8C for 30 min in closed reaction tubes with a rubber cap carrying two discs of Whatman paper containing 1 M benzethonium hydroxide. The reaction was stopped by adding 0 . 5 ml of 2 M citric acid. The discs were transferred to scintillation vials containing 10 ml scintillation fluid and counted. Activity was expressed as nmol CO 2 produced per hour and per g of wet weight tissue. DDC activity assay was highly reproducible and 14 CO 2 release was completely inhibited by 1 mM benserazide or carbidopa, two well-known DDC inhibitors.
Na
C and K C analysis in urine Na C and K C contents of urine were determined using a flame photometer (Instrumentation Laboratory, Milano, Italy). Urine was collected daily from metabolic cages. When possible, urine was also collected directly from the urinary bladder, after killing the animals. Urine samples were diluted with doubled distilled deionized water and Na C and K C contents measured by flame photometry. Results were expressed as mEq Na C or K C per mmol of creatinine. Creatinine was determined by the Jaffe method (Peñafiel et al. 1983) .
Quantitative real-time RT-PCR
Gene expression was measured by both semiquantitative and quantitative RT-PCR, using SYBR Green PCR Master Mix and a Real-Time PCR equipment (Applied Biosystems, Foster City, CA, USA), according to the manufacturer's protocols. Total RNA was extracted from tissues with GenElute mammalian total RNA Miniprep kit (Sigma Chemical Co.), following the manufacturer's instructions. Total RNA was reverse transcribed using oligo(dT) 18 as primer and MMLV reverse transcriptase (Sigma Chemical Co). For semiquantitative RT-PCR analysis, the cDNAs were amplified by means of Taq polymerase (Sigma Chemical Co.) using specific primer pairs within the linear range for each gene product. Amplified products were resolved by electrophoresis in 2% agarose gel containing 40 mM Tris/acetate and 1 mM EDTA (TAE buffer, pH 8 . 0) in a horizontal slab gel apparatus using 1!TAE buffer. The gel was stained with ethidium bromide (0 . 2 mg/ml for 15 min), followed by destaining in water, photographed by u.v. transilumination using a Gel Doc system camera (Bio-Rad Hercules, CA, USA), and the bands quantified using the MultiAnalyst software (Bio-Rad). Primers used (from SigmaGenosys) for the semiquantitative analysis of the genes analyzed were DDC, forward 5 0 -TCGAGAAGATAATCATGCCA-3 0 -and reverse 5 0 -TTCTACAGAGGAATGCGCCT-3 0 ; and b-actin, forward 5 0 -TGCGTCTGGACCTGGCTG-3 0 and reverse 5 0 -CTGCTGGAAGGTGGACAG-3 0 , which produce amplicons of 409 and 535 bp respectively. For real-time RT-PCR, the primers used for amplification were: DDC, forward 5 0 -GGACTAAAGTTATCCGCCAG-3 0 and reverse 5 0 -TTCTACAGAGGAATGCGCCT-3 0 ; and b-actin, forward 5 0 -GATTACTGCTCTGGCTCCTAGCA-3 0 , reverse 5 0 -GCTCAGGAGGAGCAATGATCTT. The lengths of the amplicons were 109 and 55 bp respectively. For analysis, a threshold was set for the change in fluorescence at a point in the linear PCR amplification phase. The levels of DDC mRNA in tissues were normalized to b-actin and calculated using the SDS 2.1 software (Applied Biosystems), which relies on the comparative C t method of quantification. At the end of the PCR, melting curves were performed to ensure that the specific amplification of the desired gene was achieved. Cycling conditions were set to 40 cycles at 95 8C for 15 s and 60 8C for 1 min (extension occurs in the temperature ramp between 60 8C and 95 8C), with an initial step of 95 8C for 10 min.
Western blot analysis
Tissues were homogenized in 50 mM Tris-HCl, pH 8, 1%
Igepal, 1 mM EDTA, and 0 . 1 mM phenylmethylsulfonyl fluoride and centrifuged at 12 000 g for 20 min. In some cases, duodenum segments were homogenized in the same solution, containing an additional mixture of protease inhibitors (13 mM bestatin, 1 . 4 mM E-64, 100 mM leupeptin, and 30 nM aprotinin). Protein concentration was determined in the supernatant using Bradford reagent (Bio-Rad). Equal amounts of protein were mixed with Laemli sample buffer, heated at 95 8C for 5 min, and fractionated by electrophoresis in 10% polyacrylamide-SDS gels. The resolved proteins were electroblotted to polyvinylidene difluoride (PVDF) membranes, and the resulting blots were incubated with 5% non-fat dry milk in PBS (0 . 01 M PBS pH 7 . 4) for 1 h. After washing in PBSC0 . 1% Tween 20 (PBST), the blots were incubated for 3 h at room temperature with rabbit polyclonal antibody against DDC (dilution 1:1000 in PBST; Calbiochem). The blots were washed with PBST and incubated overnight at 4 8C with a horseradish peroxidase-labeled secondary antibody (dilution 1:5000; Chemicon International Inc., Temecula, CA, USA). Immunoreactive bands were detected using ECL TM C detection reagent (Amersham Pharmacia Biotech) and commercial developing reagents and films (Amersham). For AR and estrogen receptor (ERa) analyses, rabbit polyclonal antibodies obtained from Santa Cruz Biotechnology Inc. were used at a dilution of 1:500. As a control of equal loading, membranes were stripped and reprobed with b-actin biotinylated antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA).
Histology and immunocytochemistry
Kidney and duodenum from male and female mice were removed and fixed in 10% formalin in PBS for 10 h. After washing in PBS, samples were processed routinely and cut into 5 mm paraffin sections. Sections were stained with hematoxylin-eosin and immunocytochemistry.
For immunocytochemistry, a two-step method was applied. Tissue sections from paraffin blocks were deparaffinized in xylene and hydrated in a graded ethanol series. Endogenous peroxidase activity was destroyed by treatment with 0 . 3% hydrogen peroxide in PBS for 30 min. Sections were washed with three 5 min changes of PBS and then incubated with normal goat serum (1:30) for 1 h, and then with rabbit polyclonal antibody to DDC (Calbiochem, dilution 1:200) for 36 h at 4 8C. After washing in PBS, they were incubated with peroxidase-conjugated goat anti-rabbit immunoglobulin (Chemicon International Inc., dilution 1:100) for 1 h, and developed with 3,3-diaminobenzidine tetra hydrochloride and 0 . 015% hydrogen peroxide. After immunostaining, sections were counterstained with hematoxylin. In controls, anti-DDC antibody was substituted by PBS.
Statistical analysis
Results are given as meansGS.E.M. The significance of the differences observed was assessed by Student's t-test or ANOVA, followed by the post hoc Newman-Keuls multiple range test. P!0 . 05 was considered statistically significant. Table 1 shows the influence of sex on the activity of DDC in different mouse tissues. Whereas in most tissues analyzed no differences in DDC activity between sexes were evident, in the kidney and in the small intestine a dimorphic and opposite pattern was found. DDC activity in the female kidney was approximately fivefold higher than in the male kidney, while the opposite was found in the small intestine. In both cases, the maximal values of DDC activity were similar to those found in the liver and the adrenal glands.
Results
To study the influence of sex hormones on this sexual dimorphism, both adult male and female mice were gonadectomized. Moreover, another group of castrated males were given 17b-estradiol benzoate for 2 weeks and adult intact females were treated with testosterone propionate for 15 days. As shown in Fig. 1A , renal DDC activity increased in the kidney of male mice after orchidectomy, although the values did not reach those found in the kidney of female mice. Treatment of castrated males with estradiol for a period of 2 weeks did not modify renal DDC activity. On the other hand, the repetitive treatment of female mice with testosterone propionate for 2 weeks elicited a marked decrease in renal DDC activity, approaching the values measured in the intact males. In the ovariectomized females, no significant changes in DDC activity were observed. Moreover, the timecourse analysis of renal DDC activity during the period of postnatal development showed that in both sexes there was a gradual increase in the enzyme activity between the second and fourth weeks of age, and that after puberty the activity markedly decreased in the males but steadily increased in the females (Fig. 1B) . These results indicate that testosterone Statistical significance: *P!0 . 001 versus males.
A J LÓ PEZ-CONTRERAS and others . DDC sexual dimorphism appears to be implicated in the regulation of renal DDC activity at least in CD1 mice. Figure 2 shows that sex differences were also evident in intestinal DDC. Here, DDC activity was higher in males than in females in the three segments of the small intestine studied. Interestingly, no significant differences were observed in the colon. Moreover, in the castrated male, DDC activity decreased in all parts of the small intestine, reaching values similar to those found in females. Furthermore, the treatment of female mice with testosterone propionate, elicited a robust increase in DDC activity in duodenum and jejunum, which was weaker in the ileum and non-significant in the colon. Figure 3A also shows that in the duodenum, like in the kidney, estrogen did not modify DDC activity, since castration of females or estradiol treatment of castrated males did not significantly affect the activity of this enzyme. The ontogenic study of DDC activity in the duodenum showed that after weaning there was an increase in DDC activity in both sexes, followed by a fall in the enzyme activity that was more marked in the females (Fig. 3B) .
The analysis of the levels of DDC mRNA in kidney and duodenum by semiquantitative RT-PCR, revealed that there were differences in the expression of DDC between sexes, with the same tendency as the one observed with DDC activity (data not shown). No differences were observed in the size of the amplified fragments between the different groups analyzed. A more precise analysis by real-time RT-PCR confirmed that the levels of DDC mRNA in the kidney of females were about sixfold higher than in males (Fig. 4A) . The analysis of DDC mRNA in castrated and hormone-treated animals also revealed significant changes that paralleled those found in DDC activity. The analysis of DDC mRNA in the duodenum also indicated that in this tissue the levels of DDC mRNA were slightly higher in the males than in the females, but that hormonal manipulation did not significantly affect mRNA expression. Moreover, there was not evident correlation with DDC activity (Fig. 4B ). Figure 5 shows that the level of expression of DDC protein, assessed by western blotting, was higher in the kidney of female mice than in the male (about 2 . 5-fold, P!0 . 01). This figure also
indicates that in the duodenum, DDC protein levels were relatively higher in males than in females (about twofold, P!0 . 01), in agreement with the results on DDC activity. In all groups, the molecular weight of the protein detected was identical, about 54 kDa, in agreement with the predicted size deduced from its amino acid sequence. As a whole, these results indicate that the differences in renal DDC activity found between sexes are related to parallel changes in DDC mRNA and DDC protein, while translational or posttranslational controls appear to participate in the regulation of duodenal DDC activity. Figure 5 also shows that ARs and ERs are expressed in both kidney and duodenum, females having a relatively higher level of expression than males. In order to know the rate of response of renal DDC to androgens, male and female mice were treated respectively with the antiandrogen flutamide and with testosterone propionate Figure 6A shows that these treatments did not significantly affect renal DDC activity. However, the levels of DDC mRNA markedly changed in both cases, the antiandrogen inducing a significant increase of the mRNA (about fourfold) in the kidney of treated males and testosterone producing a marked decrease of the mRNA concentration in the kidney of the treated females that reached values about 30% of controls (Fig. 6B ). This lack of correspondence between DDC activity and mRNA levels appears to be related with the slow turnover rate of the renal DDC, since in our hands renal DDC activity did not change after 10 or 24 h of cycloheximide treatment, in contrast to the dramatic decrease of renal ODC (results not shown).
To study the cellular localization of DDC in kidney and duodenum, DDC protein was detected by immunocytochemistry. Both male and female kidneys showed a similar immunolabeling pattern. Only proximal tubular cells were reactive to DDC antibodies. However, this reactivity was increased in the proximal straight tubular cells located in the outer stripe of the outer medulla (Fig. 7a) . Proximal convoluted tubules showed light-to-moderate immunoreactivity to DDC antibodies, whereas no reaction was observed in distal tubules (Fig. 7c) . In the proximal straight tubular cells, DDC immunoreactivity was lower in males (Fig. 7d ) than in females (Fig. 7e) . In the duodenum, DDC immunolabeling was detected in the cytoplasm of enterocytes. The reactivity was more intense in males ( Fig. 7f and g ) than in females (Fig. 7h) . Some epithelial cells in deep crypts were also strongly reactive (Fig. 7f ) .
Since dopamine, a product of DDC, has been implicated in renal sodium handling in the rat (Vieira-Coelho et al. 2000) , we decided to study the possible influence of DDC dimorphism in kidney on sodium renal absorption by measuring sodium levels in the urine of male and female mice. Table 2 shows that the relative sodium excretion in the urine of female mice was about 60% higher than in male mice. Moreover, in castrated male mice sodium urinary excretion increased, reaching values similar to those found in females, Figure 4 Influence of chronic exposure to sex hormones on DDC mRNA expression in the (A) kidney and (B) duodenum of mice. DDC mRNA was quantified by real-time RT-PCR from RNA samples obtained from kidney and duodenum of control male and female mice, gonadectomized mice 15 days after castration, castrated male treated with 17-b estradiol benzoate (E 2 , 50 mg/kg BW, sc, daily during 15 days), and intact females treated with testosterone propionate (TP, 20 mg/kg BW, sc, every other day during 15 days). Results are meansGS.E.M. of three animals per group. DDC mRNA levels were normalized with respect to those of b-actin and expressed as arbitrary units with respect to the value of control males that was taken as 1. a, P!0 . 001 versus control males; b, P!0 . 001 versus control females. Figure 5 Western blot analysis of DDC, androgen receptor, and estrogen receptor in mouse kidney and duodenum of male and female mice. Representative samples from kidney and duodenum of male and female mice. DDC, DOPA decarboxylase; AR, androgen receptor; ER, estrogen receptor-a. b-Actin was used as a loading control. For intestinal DDC, the bands from six males and six females were quantified by scanning densitometry. The values expressed in arbitrary units were 1 . 00G0 . 33 for males and 0 . 48G0 . 09 for females (P!0 . 01). whereas the treatment of female mice with testosterone reduced sodium excretion ( Table 2) . As shown in this Table, potassium values in urine were not significantly different between sexes, and orchidectomy or testosterone treatment did not affect potassium excretion. These results indicate that there is an inverse correlation between DDC activity and sodium reabsorption in the kidney, confirming the hypothesis that dopamine may inhibit sodium absorption. Unfortunately, our attempts to measure Na C levels in mouse feces yielded non-reproducible results, presumably due to contamination of the feces with urine or small fragments of the pelleted chow that precluded the analysis of sodium absorption by the gut.
Discussion
The results presented here clearly demonstrate that there is a marked sexual dimorphism in DDC activity, affecting kidney and small intestine. To our knowledge, this is the first report showing the existence of DDC gender-dependent dimorphism in CD1 mice. Moreover, it is also shown that the DDC sexual dimorphism found in kidney and intestine is opposite, since female kidneys have higher DDC activity than male ones, whereas DDC activity in the small intestine is higher in the males. Our results on the effect of gonadectomy on renal and intestinal DDC activity, besides the influence of testosterone and estradiol treatments on DDC activity of kidney and small intestine, strongly suggest that androgens may play a relevant role in DDC sexual dimorphism. This influence of testosterone on DDC renal gender-dependent dimorphism is not surprising, since it has been very well known, for quite some time, that mouse kidney is an androgen-responsive organ (Bardin & Catterall 1981 , Berger & Watson 1989 . In this respect, a considerable number of genes, including b-glucuronidase, ODC, kidney androgenregulated protein, RP2, alcohol dehydrogenase, aldehyde oxidase, and arginase II, among others, have been shown to be up-regulated by androgens in the mouse kidney (Catterall et al. 1986 , Berger & Watson 1989 , Melia et al. 1998 , Kurosaki et al. 1999 , Levillain et al. 2005 . On the contrary, it is also known that some genes, such as testosterone 16a-hydroxylase or ornithine aminotransferase, are down-regulated by androgens (Melia et al. 1998 , Levillain et al. 2005 . According to our results, the androgen-mediated regulation of DDC expression in mice appears to be complex, since testosterone elicited inverse effects on the expression of this gene in kidney and small intestine. The fact that renal DDC activity and protein in male and female mice correlated well with the concentrations of DDC mRNA in the kidney, associated with the finding that androgen ablation and androgen treatment up-regulated and down-regulated respectively DDC expression, strongly supports the possibility that in the kidney, testosterone may control DDC gene expression at the level of mRNA, either controlling DDC gene transcription or DDC mRNA stability. The lack of effect of estrogen manipulations on renal DDC expression suggests that this hormone has little effect on DDC regulation. On the other hand, in the small intestine, the absence of a precise correlation between DDC mRNA levels and DDC activities between sexes suggests that translational or post-translational mechanisms, rather than transcriptional control, may be implicated in the regulation of intestinal DDC.
The existence of ARs in the kidney and intestine of different mammals, including mice, is well documented (Pajunen et al. 1982 , Quinkler et al. 2005 , González-Montelongo et al. 2006 . Our results on receptor analysis confirm the presence of ARs in the kidney and small intestine of both sexes, and that ERs are also expressed in these tissues. However, in our case, it cannot be ascertained whether the effects of androgens on DDC expression are primary effects of the hormone on DDC gene or secondary effects resulting from steroid action at other sites. Despite that it is known that murine DDC is encoded by a single gene located on chromosome 11, to our knowledge no androgen response elements have been identified within or in the flanking regions of the DDC gene. The opposite effect of testosterone on DDC gene expression found in kidney and intestine could be related, in principle, with differences in the set of nuclear receptor co-repressors or co-activators or in other tissue-specific factors, as well as in epigenetic changes that may affect androgen action. In this regard, it must be noted that opposite effects of testosterone on other amino acid decarboxylases, such as ODC, have been also observed in different mouse tissues, where androgens dramatically increased this enzyme in the kidney but down-regulated ODC in the mouse adrenals (Bastida et al. 2007) . Furthermore, our results on the effect of androgens on renal DDC are in agreement with recent studies that concluded that human neoplastic prostate epithelium DDC is down-regulated by androgens (Nelson et al. 2002) .
The study on the cellular localization of DDC in kidney and small intestine, the tissues showing DDC genderdependent dimorphism, may be of interest in order to postulate the possible physiological relevance of DDC sex dimorphism. Our finding that DDC is mainly located in the proximal tubular cells of the kidney is in agreement with a recent report claiming that both DDC mRNA and DDC immunoreactive protein are expressed in the mouse kidney cortex (Kubovcanova et al. 2004) . Moreover, our results showing differences in urinary sodium excretion between sexes support the possibility that sex differences in dopamine production, caused by the gender dependence of DDC activity in the epithelial cells of the proximal tubule, may affect renal sodium reabsorption between sexes. This assumption is in agreement with studies that reveal that dopamine and D1-receptor agonists inhibit sodium transport mechanisms such as Na C /K C ATPase at the basolateral membrane (Aperia et al. 1987 , Seri et al. 1990 and Na C /H C exchanger at the apical membrane (Felder et al. 1990 , Gomes & Soares-da-Silva 2004 , or that testosterone may promote sodium reabsorption by stimulating Na C /H C pumps (Mackovic et al. 1986 , Quinkler et al. 2005 .
Our results on intestinal DDC could be also related to gender differences in sodium levels in the feces, since both the localization of DDC in the epithelial cells of the small intestine and the higher values of DDC activity found in the males could be consistent in principle with reduced sodium absorption by the male gut. In fact, it has been reported that in young rats fed with a high-salt diet, jejunal Na C /K C ATPase is inhibited, likely by the action of locally formed dopamine (Vieira-Coelho et al. 1998) . Moreover, decreased jejunal absorption of sodium may take place in response to partial renal ablation (Vieira-Coelho et al. 2000) . Therefore, a greater inhibition of Na C uptake in the intestinal mucosa of male mice, as a consequence of a higher dopamine production, could be associated with relatively higher levels of Na C in the feces of male mice. Unfortunately, this hypothesis could not be confirmed, since the estimation of sodium levels in the feces, in our hands, yielded non-reproducible results. On the other hand, to explain our results on the influence of androgens on DDC activity in the small intestine, one possibility is that testosterone, as pointed out before, may directly interact with ARs located in the target cells leading to DDC induction. Our results indicate that both ARs and ERs are expressed in the duodenum of male and female mice, although this does not demonstrate that sex dimorphism of intestinal DDC is related to the direct action of testosterone on DDC expression in this tissue that, unlike in the kidney, appears to be exerted at posttranscriptional level. In fact, an alternate view on the effect of this hormone on intestinal DDC is that it may be secondary to its action on the kidney. This possibility seems to be consistent with the existence of a renal-intestinal crosstalk, as it was earlier suggested (Vieira-Coelho et al. 2000) , although the mechanisms that support this possibility are far from being understood. The fact that in our ontogeny studies (Figs 2B and 4B) DDC sex dimorphism in the duodenum appears to be delayed with respect to that found in the kidney could also support the hypothesis that primary changes in DDC in the kidney may affect later the expression of this enzyme in the intestine.
In conclusion, our results reveal the existence of a marked and opposite sexual dimorphism in DDC activity in mice kidney and small intestine, which might be related with differences in Na C reabsorption by the renal tubules and mucosa cells of the small intestine. Such differences may have implications for sex-specific etiology and treatment of diseases related with these parameters, such as hypertension or renal injury, and in the sex-dependent bias observed in the response to treatments with dopaminergic drugs.
